207 related articles for article (PubMed ID: 15180309)
1. Effects of ginsenosides Rg3 and Rh2 on the proliferation of prostate cancer cells.
Kim HS; Lee EH; Ko SR; Choi KJ; Park JH; Im DS
Arch Pharm Res; 2004 Apr; 27(4):429-35. PubMed ID: 15180309
[TBL] [Abstract][Full Text] [Related]
2. Combination of ginsenoside Rg3 with docetaxel enhances the susceptibility of prostate cancer cells via inhibition of NF-kappaB.
Kim SM; Lee SY; Cho JS; Son SM; Choi SS; Yun YP; Yoo HS; Yoon DY; Oh KW; Han SB; Hong JT
Eur J Pharmacol; 2010 Apr; 631(1-3):1-9. PubMed ID: 20056115
[TBL] [Abstract][Full Text] [Related]
3. Stereoisomer-specific anticancer activities of ginsenoside Rg3 and Rh2 in HepG2 cells: disparity in cytotoxicity and autophagy-inducing effects due to 20(S)-epimers.
Cheong JH; Kim H; Hong MJ; Yang MH; Kim JW; Yoo H; Yang H; Park JH; Sung SH; Kim HP; Kim J
Biol Pharm Bull; 2015; 38(1):102-8. PubMed ID: 25744465
[TBL] [Abstract][Full Text] [Related]
4. Ginsenoside Rg3 attenuates cell migration via inhibition of aquaporin 1 expression in PC-3M prostate cancer cells.
Pan XY; Guo H; Han J; Hao F; An Y; Xu Y; Xiaokaiti Y; Pan Y; Li XJ
Eur J Pharmacol; 2012 May; 683(1-3):27-34. PubMed ID: 22426160
[TBL] [Abstract][Full Text] [Related]
5. Stereospecificity of hydroxyl group at C-20 in antiproliferative action of ginsenoside Rh2 on prostate cancer cells.
Liu J; Shimizu K; Yu H; Zhang C; Jin F; Kondo R
Fitoterapia; 2010 Oct; 81(7):902-5. PubMed ID: 20554003
[TBL] [Abstract][Full Text] [Related]
6. (20S)-Protopanaxadiol Ginsenosides Induced Cytotoxicity via Blockade of Autophagic Flux in HGC-27 Cells.
Han Q; Han L; Tie F; Wang Z; Ma C; Li J; Wang H; Li G
Chem Biodivers; 2020 Jul; 17(7):e2000187. PubMed ID: 32384197
[TBL] [Abstract][Full Text] [Related]
7. Ginsenoside Rh2 Inhibits Angiogenesis in Prostate Cancer by Targeting CNNM1.
Huang Y; Huang H; Han Z; Li W; Mai Z; Yuan R
J Nanosci Nanotechnol; 2019 Apr; 19(4):1942-1950. PubMed ID: 30486934
[TBL] [Abstract][Full Text] [Related]
8. Assessment of a New Ginsenoside Rh2 Nanoniosomal Formulation for Enhanced Antitumor Efficacy on Prostate Cancer: An in vitro Study.
Zare-Zardini H; Alemi A; Taheri-Kafrani A; Hosseini SA; Soltaninejad H; Hamidieh AA; Haghi Karamallah M; Farrokhifar M; Farrokhifar M
Drug Des Devel Ther; 2020; 14():3315-3324. PubMed ID: 32884236
[TBL] [Abstract][Full Text] [Related]
9. Production of Rare Ginsenosides Rg3 and Rh2 by Endophytic Bacteria from
Yan H; Jin H; Fu Y; Yin Z; Yin C
J Agric Food Chem; 2019 Aug; 67(31):8493-8499. PubMed ID: 31310523
[TBL] [Abstract][Full Text] [Related]
10. Changes of [3H]MK-801, [3H]muscimol and [3H]flunitrazepam binding in rat brain by the prolonged ventricular infusion of transformed ginsenosides.
Jang S; Ryu JH; Kim DH; Oh S
Neurochem Res; 2004 Dec; 29(12):2257-66. PubMed ID: 15672548
[TBL] [Abstract][Full Text] [Related]
11. Ginsenosides Rg3 and Rh2 inhibit the activation of AP-1 and protein kinase A pathway in lipopolysaccharide/interferon-gamma-stimulated BV-2 microglial cells.
Bae EA; Kim EJ; Park JS; Kim HS; Ryu JH; Kim DH
Planta Med; 2006 Jun; 72(7):627-33. PubMed ID: 16673329
[TBL] [Abstract][Full Text] [Related]
12. Rh2 synergistically enhances paclitaxel or mitoxantrone in prostate cancer models.
Xie X; Eberding A; Madera C; Fazli L; Jia W; Goldenberg L; Gleave M; Guns ES
J Urol; 2006 May; 175(5):1926-31. PubMed ID: 16600800
[TBL] [Abstract][Full Text] [Related]
13. Generation of ginsenosides Rg3 and Rh2 from North American ginseng.
Popovich DG; Kitts DD
Phytochemistry; 2004 Feb; 65(3):337-44. PubMed ID: 14751305
[TBL] [Abstract][Full Text] [Related]
14. [In vitro and in vivo effects of ginsenoside Rh2 on the proliferation of serous cystadenocarcinoma of the human ovary].
Tode T; Kikuchi Y; Sasa H; Hirata J; Kita T; Imaizumi E; Nagata I
Nihon Sanka Fujinka Gakkai Zasshi; 1992 May; 44(5):589-94. PubMed ID: 1619319
[TBL] [Abstract][Full Text] [Related]
15. Rg3 and Rh2 ginsenosides suppress embryoid body formation by inhibiting the epithelial-mesenchymal transition.
Noh JS; Jeong JK; Han JW; Yi SA
Arch Pharm Res; 2022 Jul; 45(7):494-505. PubMed ID: 35759089
[TBL] [Abstract][Full Text] [Related]
16. Inhibitory effects of Korean red ginseng and its genuine constituents ginsenosides Rg3, Rf, and Rh2 in mouse passive cutaneous anaphylaxis reaction and contact dermatitis models.
Bae EA; Han MJ; Shin YW; Kim DH
Biol Pharm Bull; 2006 Sep; 29(9):1862-7. PubMed ID: 16946499
[TBL] [Abstract][Full Text] [Related]
17. KG-135, enriched with selected ginsenosides, inhibits the proliferation of human prostate cancer cells in culture and inhibits xenograft growth in athymic mice.
Yoo JH; Kwon HC; Kim YJ; Park JH; Yang HO
Cancer Lett; 2010 Mar; 289(1):99-110. PubMed ID: 19765891
[TBL] [Abstract][Full Text] [Related]
18. 20(S)-ginsenoside Rh2, a newly identified active ingredient of ginseng, inhibits NMDA receptors in cultured rat hippocampal neurons.
Lee E; Kim S; Chung KC; Choo MK; Kim DH; Nam G; Rhim H
Eur J Pharmacol; 2006 Apr; 536(1-2):69-77. PubMed ID: 16563373
[TBL] [Abstract][Full Text] [Related]
19. Hepatoprotective effect of 20(S)-ginsenosides Rg3 and its metabolite 20(S)-ginsenoside Rh2 on tert-butyl hydroperoxide-induced liver injury.
Lee HU; Bae EA; Han MJ; Kim DH
Biol Pharm Bull; 2005 Oct; 28(10):1992-4. PubMed ID: 16204963
[TBL] [Abstract][Full Text] [Related]
20. Rh2 or its aglycone aPPD in combination with docetaxel for treatment of prostate cancer.
Musende AG; Eberding A; Jia W; Ramsay E; Bally MB; Guns ET
Prostate; 2010 Sep; 70(13):1437-47. PubMed ID: 20687217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
